Cart (0 Items)
Your cart is currently empty.
View ProductsIt looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.
Switch to US ($)
| Size | 96T |
|---|---|
| Brand | ProteoGenix |
| Product type | Elisa assay kits |
| Product name | Semaglutide ELISA Kit |
|---|---|
| Delivery condition | Blue ice (+4°C) |
| Delivery lead time in business days | 3-5 days if in stocks, 3-5 weeks if production is needed |
| Storage condition | 4°C for short term (1 week), store at -20°C to -80°C for long term(1 year); Avoid repeated freeze-thaw cycles |
| Brand | ProteoGenix |
| Aliases /Synonyms | CAS: 910463-68-2, Semaglutide, Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217 |
| Note | For research use only. |
| Immunogen | Semaglutide |
| Assay type | Quantitative |
| Detection method | Colorimetric |
| Recovery | 80-120% |
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that is currently used as a therapeutic agent for the treatment of type 2 diabetes. It works by stimulating insulin secretion and reducing glucagon secretion, leading to improved glycemic control. To accurately measure the levels of semaglutide in biological samples, a specialized tool known as the Semaglutide ELISA Kit has been developed. In this article, we will discuss the structure, activity, and application of this kit in detail.
The Semaglutide ELISA Kit is a highly sensitive and specific immunoassay designed to detect and quantify semaglutide in various biological samples such as serum, plasma, and urine. The kit is composed of several components, including microtiter plates coated with specific antibodies against semaglutide, standard solutions, and enzyme-conjugated detection antibodies. The kit also contains all the necessary reagents and buffers for the assay.
The Semaglutide ELISA Kit works on the principle of competitive enzyme-linked immunosorbent assay (ELISA). In this assay, the semaglutide present in the sample competes with a fixed amount of semaglutide conjugated to an enzyme for binding to the specific antibodies coated on the microtiter plate. After a series of washing steps to remove any unbound components, a substrate solution is added, which reacts with the bound enzyme to produce a color change. The intensity of the color is directly proportional to the amount of semaglutide present in the sample. By comparing the absorbance of the sample to that of the standard solutions, the concentration of semaglutide in the sample can be determined.
The Semaglutide ELISA Kit has multiple applications in both therapeutic target and research use settings. In the clinical setting, it is used to monitor the levels of semaglutide in patients undergoing treatment for type 2 diabetes. By regularly measuring the levels of semaglutide, healthcare professionals can adjust the dosage to achieve optimal glycemic control. This allows for personalized treatment plans for each patient.
In the research setting, the Semaglutide ELISA Kit is a valuable tool for studying the pharmacokinetics and pharmacodynamics of semaglutide. It can be used to measure the absorption, distribution, metabolism, and excretion of semaglutide in various animal models. This information is crucial for the development and optimization of new semaglutide-based therapies.
Furthermore, the Semaglutide ELISA Kit can also be used in drug discovery and development processes. By accurately measuring the levels of semaglutide in biological samples, researchers can assess the efficacy and safety of new semaglutide analogs and formulations. This can potentially lead to the development of more effective and safer treatments for type 2 diabetes.
In summary, the Semaglutide ELISA Kit is a highly sensitive and specific tool for measuring semaglutide levels in biological samples. Its structure, activity, and application make it an essential tool for both therapeutic target and research use. By providing accurate and reliable measurements of semaglutide, this kit plays a crucial role in the development and optimization of semaglutide-based therapies for the treatment of type 2 diabetes.
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.